ID   Hep293TT
AC   CVCL_D139
DR   ChEMBL-Cells; CHEMBL4513112
DR   ChEMBL-Targets; CHEMBL4513127
DR   Cosmic; 1286602
DR   PubChem_Cell_line; CVCL_D139
DR   Wikidata; Q54882806
RX   PubMed=19637320;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Val22_Leu139delinsVal (c.66_416del351); Zygosity=Heterozygous (PubMed=19637320).
CC   Omics: Array-based CGH.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=19637320
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,14
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9.3
ST   TPOX: 10,12
ST   vWA: 15,17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
RX   PubMed=19637320; DOI=10.1002/pbc.22187;
RA   Chen T.T.-L., Rakheja D., Hung J.Y., Hornsby P.J., Tabaczewski P.,
RA   Malogolowkin M.H., Feusner J., Miskevich F., Schultz R., Tomlinson G.E.;
RT   "Establishment and characterization of a cancer cell line derived from
RT   an aggressive childhood liver tumor.";
RL   Pediatr. Blood Cancer 53:1040-1047(2009).
//